Emerald Mutual Fund Advisers Trust Collegium Pharmaceutical, Inc Transaction History

Emerald Mutual Fund Advisers Trust

$1.47 Billion
Q2 2025

A detailed history of Emerald Mutual Fund Advisers Trust transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 550,634 shares of COLL stock, worth $18.9 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

550,634

Previous 574,080 4.08%

Holding current value

$18.9 Million

Previous $17.1 Million 4.98%

% of portfolio

1.11%

Previous 1.39%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$24.67 - $30.44 $578,412 - $713,696	-23,446 Reduced 4.08%	550,634 $16.3 Million
Q1 2025 May 01, 2025	BUY	$28.04 - $33.91 $126,544 - $153,035	4,513 Added 0.79%	574,080 $17.1 Million
Q4 2024 Feb 14, 2025	SELL	$28.61 - $41.86 $2.65 Million - $3.88 Million	-92,724 Reduced 14.0%	569,567 $16.3 Million
Q3 2024 Oct 29, 2024	BUY	$31.4 - $39.07 $4.14 Million - $5.15 Million	131,835 Added 24.85%	662,291 $25.6 Million
Q2 2024 Aug 06, 2024	BUY	$31.36 - $39.99 $603,836 - $770,007	19,255 Added 3.77%	530,456 $17.1 Million
Q1 2024 May 08, 2024	SELL	$31.23 - $40.91 $1.27 Million - $1.66 Million	-40,593 Reduced 7.36%	511,201 $19.8 Million
Q4 2023 Feb 05, 2024	SELL	$21.16 - $30.8 $162,635 - $236,728	-7,686 Reduced 1.37%	551,794 $17 Million
Q3 2023 Oct 26, 2023	SELL	$21.23 - $24.28 $2.5 Million - $2.86 Million	-117,680 Reduced 17.38%	559,480 $12.5 Million
Q1 2023 May 04, 2023	SELL	$23.0 - $29.88 $200,859 - $260,942	-8,733 Reduced 1.27%	677,160 $16.2 Million
Q4 2022 Feb 03, 2023	SELL	$16.14 - $23.55 $153,330 - $223,725	-9,500 Reduced 1.37%	685,893 $15.9 Million
Q3 2022 Oct 25, 2022	SELL	$15.46 - $20.1 $192,415 - $250,164	-12,446 Reduced 1.76%	695,393 $11.1 Million
Q2 2022 Jul 29, 2022	BUY	$14.22 - $20.88 $556,855 - $817,660	39,160 Added 5.86%	707,839 $12.5 Million
Q1 2022 Apr 29, 2022	BUY	$17.2 - $22.5 $314,433 - $411,322	18,281 Added 2.81%	668,679 $13.6 Million
Q4 2021 Feb 02, 2022	SELL	$17.5 - $21.35 $1.05 Million - $1.28 Million	-60,000 Reduced 8.45%	650,398 $12.1 Million
Q3 2021 Oct 28, 2021	SELL	$17.75 - $25.39 $1.42 Million - $2.03 Million	-79,993 Reduced 10.12%	710,398 $14 Million
Q1 2021 Apr 29, 2021	BUY	$19.25 - $26.1 $45,468 - $61,648	2,362 Added 0.3%	790,391 $18.7 Million
Q4 2020 Jan 29, 2021	BUY	$17.83 - $22.29 $2.51 Million - $3.14 Million	140,700 Added 21.74%	788,029 $15.8 Million
Q3 2020 Oct 28, 2020	BUY	$15.78 - $20.82 $1.94 Million - $2.56 Million	123,066 Added 23.47%	647,329 $13.5 Million
Q2 2020 Jul 28, 2020	SELL	$15.49 - $23.51 $2.28 Million - $3.46 Million	-147,032 Reduced 21.9%	524,263 $9.18 Million
Q1 2020 Apr 30, 2020	SELL	$13.89 - $25.45 $1.3 Million - $2.38 Million	-93,617 Reduced 12.24%	671,295 $11 Million
Q4 2019 Jan 29, 2020	BUY	$10.7 - $22.24 $8.18 Million - $17 Million	764,912 New	764,912 $15.7 Million

Others Institutions Holding COLL

# of Institutions

241

Shares Held

36.4M

Call Options Held

52.5K

Put Options Held

200

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.17B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account

Emerald Mutual Fund Advisers Trust Collegium Pharmaceutical, Inc Transaction History